Pediatric Oncology
Subcommittee of Oncologic Drugs Advisory Committee
Bibliography
The following background readings are intended to facilitate the
discussion.
1. Current Product Label
Purinethol
2. Lennard L, Gibson BES,
Nicole T, Lilleyman JS.
Congenital Thiopurine Methyltransferase Deficiency And 6-Mercaptopurine Toxicity During Treatment For Acute Lymphoblastic Leukemia. Arch Dis Child. 69:577-579. 1993;
3.
Yates C, Krynetski EY,
Loennechen, T Fessing M; Tai, H-L
Pui C-H, Relling MV Evans WE
Molecular
Diagnosis Of Thiopurine S-Methyltransferase
Deficiency: Genetic Basis For Azathioprine And Mercaptopurine Intolerance. Annals of Internal Medicine 126:608-614. 1997
4. Relling
MV, Hancock ML, Rivera GK, Sandlund JT, Ribeiro RC, Krynetski EY, Pui C-H,
Evans WE
Mercaptopurine Therapy
Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene
Locus, Journal of The National Cancer Institute, 91 (23): 2001-20081999
5. Evans
WE, Hon YY, Bomgaars L, Coutre S, Holdsworth M, Janco R, Kalwinsky D, Keller F,
Khatib Z, Margolin J, Murray J, Quinn J, Ravindranath Y, Ritchey K, Roberts W,
Rogers ZR, Schiff D, Steuber C, Tucci F, Kornegay N, Krynetski EY, Relling MV
Preponderance
of Thiopurine S-Methyltransferase Deficiency and Heterozygosity among Patients
Intolerant to Mercaptopurine or Azathioprine. J Clin Oncol 19:2293-2301, 2001
6. Weinshilboum
R
Thiopurine Pharmacogenetics:
Clinical and Molecular Studies of Thiopurine Methyltransferase
Drug Metabolism and
Disposition Vol. 29, No. 4, Part 2, 601-605, 2001
7.
6-Thioguanine in children with
acute lymphoblastic leukaemia: Influence of food on parent drug
pharmacokinetics and 6-thioguanine nucleotide concentrations. J Clin Pharmacol, 51, 531-539 2001
8. Lennard
L, Lewis IJ, Michelagnoli M, Lilleyman
JS
Thiopurine Methyltransferase
Deficiency in Childhood Lymphoblastic Leukaemia: 6-Mercaptopurine Dosage
Strategies. Med. Pediatr. Oncol. 29:252–255, 1997
9.
Lennard L
, S. Chew T Lilleyman JS
Human thiopurine
methyltransferase activity varies with red blood cell age. J Clin Pharmacol, 52, 539-546 2001
Pediatric Oncology
Subcommittee of Oncologic Drugs Advisory Committee
Bibliography Continued
Principles
for International Cooperative Studies
10.
11.
12.
13.
14. National
Institutes of Health Guidelines on the Inclusion of Children as Participants in
Research Involving Human Subjects, 1998
15.
16. International
Conference on Harmonization Efficacy Document 11: Clinical Investigation of
Medicinal Products in the Pediatric Population
17. National
Bioethics Advisory Committee Ethical and Policy Issues in Research Involving
Human Participants, 2001
18. World
Medical Association, Declaration of